NCT00479895View on ClinicalTrials.gov

Hemoglobin Based Oxygen Therapeutics in Elective Percutaneous Coronary Revascularization

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

April 30, 2008

Conditions
Coronary OcclusionAcute Coronary Syndrome
Interventions
DRUG

Hemoglobin Based Oxygen Carrier-201 (HBOC-201, Hemopure)

Pre-oxygenated HBOC-201

Trial Locations (1)

Unknown

Thoraxcentre - Erasmus MC, Rotterdam

Sponsors
All Listed Sponsors
lead

Biopure Corporation

INDUSTRY